FundedIQ
Biotechnology

Stemnovate: Funding, Investors & Team (Oct 2026)

Stemnovate is a unique, innovative drug development platforms enable the right patients to be targeted with the right treatments, at the right time.

stemnovate.co.uk LinkedIn Babraham, United Kingdom 11-50 employees
Total raised
$1.2M
Rounds
1
Latest
Grant
Aug 2022

Stemnovate has raised $1.2M across 1 funding round on record, the most recent a Grant of $1.2M announced in Aug 2022.

That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Stemnovate Company Profile and Key Stats

Total funding raised
$1.2M
across 1 round on record
Funding rounds on record
1
Latest funding round
Grant
$1.2M in Aug 2022
Employees
11-50
reported band
Headquarters
Babraham, United Kingdom

Latest funding round on record: Aug 2022.

Stemnovate Funding Rounds

Date
Round
Amount
Grant
$1.2M

Stemnovate Founders and Leadership Team

Name
Role
Contact
Adrian Fisher
Founder
—

No contact details are on record for this team yet.

Stemnovate Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
5,368
$4.1M
1,065
—

Stemnovate's latest round of $1.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Stemnovate in Biotechnology and Babraham

Companies Similar to Stemnovate

Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…

Series C $40.4M

OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…

Series C $310M

HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…

Series A $8.0M

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…

Undisclosed round $9.3M

Argonaute RNA company research projects build on existing intellectual property.

Undisclosed round $1.8M

An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…

Undisclosed round $1.8M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

Stemnovate Funding FAQs

What does Stemnovate do?

Stemnovate is a unique, innovative drug development platforms enable the right patients to be targeted with the right treatments, at the right time.

How much funding has Stemnovate raised?

Stemnovate has raised $1.2M across 1 round on record. The most recent is a Grant of $1.2M announced in Aug 2022.

When did Stemnovate last raise funding?

Stemnovate's most recent funding round on record is a Grant of $1.2M, announced in Aug 2022.

Who founded Stemnovate?

FundedIQ lists Adrian Fisher (Founder) at Stemnovate.

Where is Stemnovate headquartered?

Stemnovate is based in Babraham, Cambridgeshire, United Kingdom.

How many employees does Stemnovate have?

Stemnovate is in the 11-50 employee band.

How does Stemnovate's funding compare to other Biotechnology startups?

Stemnovate's latest round of $1.2M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Stemnovate Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Stemnovate is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.